Drug shortage: Lidocaine Hydrochloride Injection (LIDOCAINE HYDROCHLORIDE, LIDOCAINE, XYLOCAINE)
FDA lists 67 presentations as Current. Availability: Unavailable (18), Available (47). Reason: Demand increase for the drug; Other. Companies: Eugia US LLC, Huons Co., Ltd. (South Korea), Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC….
- Published by source
- 2012-02-22
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Eugia US LLC
- Products
- Lidocaine Hydrochloride Injection LIDOCAINE HYDROCHLORIDE LIDOCAINE XYLOCAINE LIDOCAINE HYDROCHLORIDE AND DEXTROSE XYLOCAINE MPF
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Check wholesalers for inventory
- Estimated recovery: TBD
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2012-02-22
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #854 | new | 2026-10-22 | 537896663553…123101 | 1dcf95e9527d…3b22c6 |
Chain head: #1076 8ad5adc30b9b…88ce20